MX2021002619A - Uso de un extracto de agave para fortalecer la funcion de barrera de la piel, del cuero cabelludo y/o de las mucosas y modular la microbiota cutanea. - Google Patents

Uso de un extracto de agave para fortalecer la funcion de barrera de la piel, del cuero cabelludo y/o de las mucosas y modular la microbiota cutanea.

Info

Publication number
MX2021002619A
MX2021002619A MX2021002619A MX2021002619A MX2021002619A MX 2021002619 A MX2021002619 A MX 2021002619A MX 2021002619 A MX2021002619 A MX 2021002619A MX 2021002619 A MX2021002619 A MX 2021002619A MX 2021002619 A MX2021002619 A MX 2021002619A
Authority
MX
Mexico
Prior art keywords
skin
scalp
enhancing
barrier function
agave extract
Prior art date
Application number
MX2021002619A
Other languages
English (en)
Inventor
Céline Laperdrix
Stéphane Desaint
Nathalie Collard
Original Assignee
Laboratoires De Biologie Vegetale Yves Rocher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires De Biologie Vegetale Yves Rocher filed Critical Laboratoires De Biologie Vegetale Yves Rocher
Publication of MX2021002619A publication Critical patent/MX2021002619A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere al uso cosmético no terapéutico de un extracto de agave para mejorar la función de barrera de la piel, el cuero cabelludo y/o las mucosas. La presente invención también se refiere a un método cosmético no terapéutico para mejorar la función de barrera de la piel, el cuero cabelludo y/o las mucosas, que comprende la aplicación de un extracto de agave a la piel, el cuero cabelludo y/o las mucosas. La presente invención se refiere además a un extracto de agave para su uso en el tratamiento y/o prevención de una inflamación de la piel, del cuero cabelludo y/o de las mucosas, ligada a la presencia de al menos un microorganismo elegido entre Cutibacterium acnes, Malassezia restricta, Staphylococcus epidermis y Malassezia sp.
MX2021002619A 2018-09-28 2019-09-25 Uso de un extracto de agave para fortalecer la funcion de barrera de la piel, del cuero cabelludo y/o de las mucosas y modular la microbiota cutanea. MX2021002619A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1858968A FR3086542B1 (fr) 2018-09-28 2018-09-28 Utilisation d'un extrait d'agave pour renforcer la fonction barriere de la peau, du cuir chevelu et/ou des muqueuses et moduler le microbiote cutane
PCT/FR2019/052256 WO2020065213A1 (fr) 2018-09-28 2019-09-25 Utilisation d'un extrait d'agave pour renforcer la fonction barrière de la peau, du cuir chevelu et/ou des muqueuses et moduler le microbiote cutané

Publications (1)

Publication Number Publication Date
MX2021002619A true MX2021002619A (es) 2021-06-23

Family

ID=65243986

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021002619A MX2021002619A (es) 2018-09-28 2019-09-25 Uso de un extracto de agave para fortalecer la funcion de barrera de la piel, del cuero cabelludo y/o de las mucosas y modular la microbiota cutanea.

Country Status (4)

Country Link
EP (1) EP3856353A1 (es)
FR (1) FR3086542B1 (es)
MX (1) MX2021002619A (es)
WO (1) WO2020065213A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3115198B1 (fr) * 2020-10-16 2023-10-27 Oreal Composition cosmétique nettoyante comprenant deux tensioactifs, un diol spécifique et un fructane

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2551972B1 (fr) * 1983-09-21 1986-05-16 Bouzid Moussaad Lotion antipelliculaire et anti-chute
JP4169814B2 (ja) * 1997-08-04 2008-10-22 一丸ファルコス株式会社 リュウゼツラン又はサイザル抽出物含有皮膚外用剤
JP2002193820A (ja) * 2000-12-28 2002-07-10 Kose Corp 皮膚外用剤及び皮膚外用剤組成物
FR2831059B1 (fr) * 2001-10-18 2004-07-23 Jean Noel Thorel Utilisation des fructo-oligosaccharides comme actifs cosmetiques, compositions les comprenant et procede de conservation les utilisant
EP1541117A1 (en) * 2003-12-12 2005-06-15 Tiense Suikerraffinaderij N.V. Cosmetic rinse-off compositions comprising inulin-type fructan
KR101096393B1 (ko) * 2009-03-09 2011-12-20 (주)아모레퍼시픽 보습용 화장료 조성물
KR101571387B1 (ko) * 2015-07-09 2015-11-24 주식회사 아미코스메틱 용설란잎 복합 추출물을 함유하는 화장료 조성물
FR3063638B1 (fr) * 2017-03-07 2021-07-16 Laboratoires De Biologie Vegetale Yves Rocher Utilisation d'extraits d'agave pour proteger la fibre capillaire

Also Published As

Publication number Publication date
FR3086542A1 (fr) 2020-04-03
WO2020065213A1 (fr) 2020-04-02
FR3086542B1 (fr) 2021-01-08
EP3856353A1 (fr) 2021-08-04

Similar Documents

Publication Publication Date Title
MY195500A (en) Vesicles Derived From Lactobacillus Paracasei And Use Of Same
MX2017007829A (es) Composicion antimicrobiana.
PH12019502646A1 (en) Pyrazole magl inhibitors
WO2019030762A3 (en) CANNABIS AND ITS DERIVATIVES FOR THE TREATMENT OF PAIN RELATED TO PAIN AND BONE REGENERATION ASSOCIATED WITH BONE DEFECTS IN THE JAW
MX2020006191A (es) Bacteriocinas terapeuticas.
WO2020021477A3 (en) Compositions and methods for treating the eye
MX365366B (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
BR112021016056A2 (pt) Anticorpos de claudina 6 e usos dos mesmos
MX2018008903A (es) COMPOSICIONES Y METODOS DE USO DE ß-HIDROXI-ß-METILBUTIRATO (HMB) PARA MODULAR AUTOFAGIA Y LIPOFAGIA.
MX2020003762A (es) Composiciones cosmeticas y metodo para tratar la piel.
WO2019236765A8 (en) Acylated catechin polyphenols and methods of their use for the treatment of cancer
ZA202102702B (en) Synergistic disinfectant compositions having enhanced antimicrobial efficacy and stability, and methods of using the same
NI202000085A (es) Moduladores de la expresión de apol1
MX2021004755A (es) Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrizacion de heridas y la recuperacion posoperatoria.
PH12021550122A1 (en) Solubilized apyrases, methods and use
EP4269549A3 (en) Skin cleansing compositions
BR112019004791A2 (pt) tratamento de esclerose múltipla com chs-131
MX2021002619A (es) Uso de un extracto de agave para fortalecer la funcion de barrera de la piel, del cuero cabelludo y/o de las mucosas y modular la microbiota cutanea.
ZA202106519B (en) Caspase inhibitors and methods of use thereof
PH12021550121A1 (en) Methods of treating hfpef employing dapagliflozin and compositions comprising the same
BR112021022619A2 (pt) Retardo de efeito de pico e/ou prolongamento de duração de resposta
MX2016009887A (es) Procedimiento para el tratamiento de enfermedades infecciosas utilizando una composicion que comprende inmunoglobulina m (igm) derivada de plasma.
MX2020012990A (es) Formulaciones de tegavivint y compuestos relacionados.
EA201992234A1 (ru) Средство для профилактики миопии, лечения миопии и/или предотвращения прогрессирования миопии, включающее тиотропий в качестве активного ингредиента
MX2019011951A (es) Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.